Company / Current Assets per Share
Krystal Biotech, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$35.58
FY2025
5-year range
$15.05 / $35.58
FY2021-FY2025
Trend
+35.4%
vs FY2024
Sector context
#16 of 210
Health Care
What the data says
Among 210 Health Care companies, Krystal Biotech, Inc. is in the top 8% for current assets per share. Current Assets per Share has increased for 3 consecutive years, from $15.05 in FY2022 to $35.58 in FY2025.
Based on SEC 10-K filings.
35.58 in FY2025 with a 5-year CAGR of +19.4%. Top quartile in the Health Care sector.
Improved from $22.82 to $35.58 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +33.2%
- 5-Year CAGR
- +19.4%
- 10-Year CAGR
- -
Sector benchmark
-79.1% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 35.4% year-over-year.
- Ranks #16 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.58 | +35.4% |
| FY2024 | $26.28 | +15.2% |
| FY2023 | $22.82 | +51.6% |
| FY2022 | $15.05 | -24.4% |
| FY2021 | $19.92 | +36.1% |
| FY2020 | $14.64 | +18.9% |
| FY2019 | $12.32 | +22.5% |
| FY2018 | $10.06 | +8.0% |
| FY2017 | $9.31 | +276.7% |
| FY2016 | $2.47 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026